Opening book details…
About this Medicine article
Differences in clinical outcome between docetaxel and abiraterone acetate as the first-line treatment in chemo-naïve metastatic castration-resistant prostate cancer patients with or without the ineligible clinical factors of the COU-AA-302 study by Poon, Darren M.C.; Chan, Kuen; Lee, Siu H.; Chan, Tim W.; Sze, Henry; Lee, Eric K.C.; Lam, Daisy; Chan, Michelle F.T. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Poon, Darren M.C.; Chan, Kuen; Lee, Siu H.; Chan, Tim W.; Sze, Henry; Lee, Eric K.C.; Lam, Daisy; Chan, Michelle F.T.
- Publisher
- Elsevier ; Elsevier Inc.; Seoul: Asian Pacific Prostate Society; Seoul: Elsevier Korea LLC; Elsevier BV (ISSN 2287-8882)
- Published
- 2017
- Language
- EN
- Field
- Medicine (Health Sciences)